Filter By:
January 19, 2021Client News
Globality Raises $138.3M Series E Financing

Gunderson Dettmer represented client Globality, an AI-powered digital solution for sourcing strategic services, in its $138.3 million Series E financing round led by Sienna Capital.

More
January 12, 2021Client News
Gro Intelligence Raises $85M Series B Financing

Gunderson Dettmer represented client Gro Intelligence, an AI-powered insights company, in its $85 million Series B financing round co-led by Intel Africa and Africa Internet Ventures.

More
January 11, 2021Client News
Genalyte Raises $50M in Financing

Gunderson Dettmer represented client Genalyte, a leading diagnostics and analytics company, in its $50 million financing round led by Verily.

More
January 8, 2021Client News
Affinivax $226M Series C Financing

Gunderson Dettmer represented client Affinivax, a clinical stage biopharmaceutical company, in its $226 million Series C financing co-led by Rock Springs Capital and Foresite Capital.

More
January 7, 2021Client News
Xencor Collaboration with MD Anderson

Gunderson Dettmer represented client Xencor, a clinical-stage biopharmaceutical company, in its collaboration agreement with MD Anderson to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer.

More
January 6, 2021Client News
Dragoneer Investment in PointClickCare

Gunderson Dettmer represented Dragoneer in increasing its investment in PointClickCare, a cloud-based healthcare software for the long-term and post-acute care market.

More
December 22, 2020Client News
WeRide Raises $200M Series B Financing

Gunderson Dettmer represented client WeRide, a Chinese startup developing autonomous vehicles, in its $200 million Series B financing round led by Yutong Group.

More
December 15, 2020Client News
Overland Pharma Joint Venture with Allogene Therapeutics

Gunderson Dettmer represented client Overland Pharma in its joint venture with Allogene Therapeutics forming new company, Allogene Overland Biopharm, a separate venture that will develop, manufacture and commercialize allogeneic CAR T (AlloCAR T™) therapies for patients with cancer in greater China, Taiwan, South Korea and Singapore.

More
December 14, 2020Client News
Dubsmash Acquisition by Reddit

Gunderson Dettmer represented client Dubsmash, a lip-syncing video application, in its acquisition by Reddit.

More
December 14, 2020Client News
Overland Pharma Joint Venture with ADC Therapeutics

Gunderson Dettmer represented client Overland Pharma in its joint venture with ADC Therapeutics forming new company, Overland ADCT BioPharma (CY) Limited, that will develop and commercialize four of ADC Therapeutics’ antibody drug conjugate (ADC) product candidates for difficult-to-treat hematologic and solid tumors in greater China and Singapore.

More
December 10, 2020Client News
Cityblock Health Raises $160M Series C Financing

Gunderson Dettmer represented client Cityblock Health, a startup improving health care for low-income patients with complex medical needs, in its $160 million Series C financing led by General Catalyst.

More
December 9, 2020Client News
PepGen Raises $45M Series A Financing

Gunderson Dettmer represented client PepGen, a therapeutics company targeting severe neuromuscular diseases, in its $45 million Series A financing led by RA Capital Management.

More
December 9, 2020Client News
Squire Raises $60M Series C Financing

Gunderson Dettmer represented client Squire, a startup that sells software to barbershops, in its $60 million Series C financing led by Iconiq Capital. The raise is $45 million in equity capital and $15 million in debt financing.

More
December 7, 2020Client News
Xencor Collaboration with Janssen Biotech, Inc.

Gunderson Dettmer represented client Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, in its research collaboration and license agreement with Janssen Biotech, Inc.

More
December 3, 2020Client News
Trash acquisition by VSCO

Gunderson Dettmer represented client Trash, an AI-powered video editing app, in its acquisition by VSCO.

More
November 20, 2020Client News
Andreessen Horowitz Closes $4.5B in Two New Funds

Gunderson Dettmer represented client Andreessen Horowitz, a venture capital firm that invests in seed to late-stage technology companies, in its closing of two new funds, Fund VII and Growth II, totaling $4.5 billion.

More
November 18, 2020Client News
Abacus.AI Raises $22M Series B Financing

Gunderson Dettmer represented client Abacus.AI, a San Francisco startup that seeks to automate deep learning models for customers, in its $22M Series B financing led by Coatue.

More
November 18, 2020Client News
Instana Acquisition by IBM

Gunderson Dettmer represented client Instana, an applications performance management startup with a cloud native approach, in its acquisition by IBM.

More